Entera Bio Ltd
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About ENTX
Entera Bio Ltd is an Israel-based clinical-stage biopharmaceutical company focused on the development and commercialization of orally delivered large molecule therapeutics for use in areas with unmet medical need and where adoption of injectable therapies is limited due to cost, convenience and compliance challenges for patients. The Company developed a platform that enables the oral delivery of injectable proteins and large molecules. Entera Bio candidates are EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism. Both EB613 and EB612 are oral formulations of human parathyroid hormone (1-34), or Parathormon (PTH). The products are administered via injection.
Find out what a historical investment in Entera Bio Ltd would be worth today using our ENTX stock calculator.
$99.05M
-
0.00%
95.81K
$2.19
$2.12
$2.19
$3.22
$1.50
Ready to start your investing journey with Stake?
Open an accountENTX FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in ENTX
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in ENTX
on Stake
Buy ENTX from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of ENTX from only US$10 with fractional shares
